14. 10 Dec 2010 IKSDC 5 The Host Institution 2 The Community 3 DST/NIKSO 1 NIKMAS 6 IK Specialists & users 4 NRS Role Players & Relationships Contract Protection IP agreements Hosting & Management Data transfer Usage Rules Data mining Cross-faculty support Structure and funding Trust and knowledge transfer agreements
15.
16.
17.
18. National Science and Technology Policy Evolution 10 Dec 2010 White Paper on S & T [1996] National Biotechnology Strategy [2001] National Research and Development Strategy [2002] Indigenous Knowledge System Policy [2004] Farmer to Pharma Space Energy Global Change Human and Social Dynamics DST’s Ten Year Innovation Plan [2008] BioEconomy
19. 10 Dec 2010 Biodiversity Indigenous Knowledge Biotechnology IKS-Biotech-Biodiversity Interface
20. IKS Research and Development 10 Dec 2010 IKS Research Management Review at National Research Foundation Applied and Innovative IKS Research Developed and Implemented the New IKS Research Management Model Identified and Funding New IKS Research Priorities IKS Curriculum Studies and Epistemologies Medicinal Food and Nutritional Medicines Indigenous and Appropriate Technologies
21. IKS Human Capital Development 10 Dec 2010 Establishment of the Centre of Excellence on African-IKS Establishment of IKS Research Chairs University of KwaZulu-Natal Indigenous Health Chair and Lab CSIR Biosciences and MRC IKS Laboratories Bachelor of Indigenous Knowledge Systems Establishment of IKS Research Laboratories Walter Sisulu University Knowledge Systems Studies Chair
22. 10 Dec 2010 Biodiversity Indigenous Knowledge And Systems Scientific and Technological Know-How IK Innovation Political Will
23. National Disease Priorities 10 Dec 2010 Communicable Diseases Chronic Diseases Tuberculosis HIV/AIDS Malaria Epidemic-Prone Diabetes Hypertension Cancer Asthma
24. National Priorities Alignment 10 Dec 2010 Health and Food Security Rural Development and Job Creation Human Capital Development and Infrastructure Research, Development and Innovation Traditional Medicines Food Technology Cosmeceutical s Commercialisation 5 Products by 2018 3 Spin-Off Companies R3bn Trust Fund
25. 10 Dec 2010 B.P.D.P. Consortia Bioprospecting and Product Development Platform Traditional Medicines Nutriceuticals Cosmeceuticals Flagships Bio-Economy
26. IKS Value Addition Consortium 10 Dec 2010 IK Holders Government Researcher Private Partnership
27. 10 Dec 2010 Bioprospecting Flagships Traditional Medicines Nutriceuticals Cosmeceuticals Bio-Economy Projects Knowledge Economy Industries Diabetes HIV/AIDS Tuberculosis Asthma Hair Loss [Baldness] Skin Care [Anti-Aging] Oral Products Fragrances [Perfumes ] Nutritional Supplements Immune Boosters Detoxifiers Flavourants
29. Thank You for the opportunity 10 Dec 2010 Thank You Social ecology Public health and medicines Biodiversity Indigenous technologies Indigenous food and food technologies Cosmology From Muthi & Myths, Heather Dugmore and Ben-Erik van Wyk
Notas del editor
The Zulu Personal Declaration (South Africa: 1825) from: M.K. Asante and A. S. Abary (eds.) African Intellectual Heritage Philandephia: Temple university Press: 1996), 371-378.
Role players 1-4 already exists. Important to note that the IKS Centre is the responsibility of NIKSO to establish. Meraka Institute was identified as an entity of DST to implement NIKMAS which is the multi media system platform and database that will support the IKS Centre in its operations.
The Farmer to Pharma Grand Challenge is seen as a value chain to strengthen the bio-economy and over the next decade South Africa must become a world leader in biotechnology and pharmaceuticals, based on the nation’s indigenous resources and expanding knowledge base. Consequently, the Farmer to Pharma is conceptualised as the interface or integration of our rich natural biodiversity, indigenous knowledge and applied biotechnology.
The Farmer to Pharma Grand Challenge is seen as a value chain to strengthen the bio-economy and over the next decade South Africa must become a world leader in biotechnology and pharmaceuticals, based on the nation’s indigenous resources and expanding knowledge base. Consequently, the Farmer to Pharma is conceptualised as the interface or integration of our rich natural biodiversity, indigenous knowledge and applied biotechnology.